Skip to main content

Table 3 OR (95 % CI) for subjective hearing loss by fibromyalgia, socioeconomic conditions, measured hearing loss, depression and anxiety in women and mena

From: Are persons with fibromyalgia or other musculoskeletal pain more likely to report hearing loss? A HUNT study

 

Subjective hearing loss

Unadjusted

Adjusted for age, education and hearing loss (model 1)

In addition adjusted for anxiety and depression (model 2)

Yes

No

N (%)

N (%)

OR (95% CI)

OR (95% CI)

OR (95% CI)

WOMEN (13 135)

1 085 (8.26)

12 050 (91.74)

   

Fibromyalgia

     

 No

805 (6.79)

11 055 (93.21)

1.000 ref

1.000 ref

1.000 ref

 Yes

280 (21.96)

995 (78.04)

3.865 (3.324–4.493)

5.182 (4.278–6.277)

4.578 (3.622–5.787)

Age

 20–35

89 (2.09)

4 162 (97.91)

1.000 ref

1.000 ref

1.000 ref

 36–49

135 (3.36)

3 881 (96.64)

1.627 (1.240–2.133)

1.069 (0.801–1.426)

0.974 (0.713–1.329)

 50–64

279 (10.24)

2 445 (89.76)

5.336 (4.182–6.809)

2.072 (1.565–2.743)

1.952 (1.437–2.651)

 65+

582 (27.15)

1 562 (72.85)

17.424 (13.837–21.942)

2.354 (1.747–3.172)

2.071 (1.474–2.909)

Education

 Primary school

659 (15.45)

3 606 (84.55)

1.000 ref

1.000 ref

1.000 ref

 High school

247 (4.49)

5 255 (95.51)

0.257 (0.221–0.299)

0.807 (0.665–0.980)

0.736 (0.588–0.921)

 Higher

179 (5.15)

3 189 (94.69)

0.307 (0.259–0.365)

0.811 (0.658–1.000)

0.799 (0.618–1.032)

WHO hearing impairment

 None (<26 dB)

377 (3.31)

11 007 (96.69)

1.000 ref

1.000 ref

1.000 ref

 Mild (26–40 dB)

325 (28.33)

822 (71.67)

11.544 (9.793–13.606)

7.859 (6.404–9.644)

8.082 (6.340–10.302)

 Moderate (41–60 dB)

291 (59.75)

196 (40.25)

43.348 (35.201–53.380)

31.533 (24.444–40.678)

35.904 (26.424–48.786)

 Severe (>60 dB)

92 (78.63)

25 (21.37)

107.442 (68.247–169.148)

81.067 (50.190–130.939)

90.053 (49.378–164.234)

HADS–A ≥8b

 No

606 (6.11)

9 312 (93.89)

1.000 ref

 

1.000 ref

 Yes

178 (11.83)

1 327 (88.17)

2.061 (1.727–2.460)

 

1.732 (1.353–2.217)

HADS-D ≥8b

 No

786 (6.91)

10 590 (93.09)

1.000 ref

 

1.000 ref

 Yes

155 (17.44)

734 (82.56)

2.845 (2.358–3.433)

 

1.131 (0.849–1.508)

Nagelkerke R2

   

0.389

0.375

−2 Log likelihood

   

5 056.265

3 744.466

MEN (12 551)

1 404 (11.19)

11 147 (88.81)

   

Fibromyalgia

 No

1 335 (10.82)

11 008 (89.18)

1.000 ref

1.000 ref

1.000 ref

 Yes

69 (33.17)

139 (66.83)

4.093 (3.050–5.493)

4.368 (3.082–6.189)

4.523 (3.077–6.647)

Age

 20–35

150 (3.93)

3 666 (96.07)

1.000 ref

1.000 ref

1.000 ref

 36–49

173 (4.54)

3 638 (95.46)

1.162 (0.930–1.453)

1.007 (0.800–1.268)

0.966 (0.757–1.233)

 50–64

332 (12.40)

2 346 (87.60)

3.459 (2.833–4.223)

1.692 (1.351–2.119)

1.609 (1.262–2.050)

 65+

749 (33.35)

1 497 (66.65)

12.228 (10.159–14.718)

2.116 (1.661–2.695)

1.837 (1.404–2.403)

Education

 Primary school

611 (19.72)

2 487 (80.28)

1.000 ref

1.000 ref

1.000 ref

 High school

505 (8.22)

5 636 (91.78)

0.365 (0.321–0.414)

0.914 (0.783–1.066)

0.886 (0.757–1.233)

 Higher

288 (8.70)

3 024 (91.30)

0.388 (0.334–0.450)

0.824 (0.691–0.981)

0.765 (0.622–0.940)

WHO hearing impairment

 None (<26 dB)

438 (4.36)

9 618 (95.64)

1.000 ref

1.000 ref

1.000 ref

 Mild (26–40 dB)

439 (28.16)

1 120 (71.84)

8.607 (7.437–9.961)

5.625 (4.713–6.715)

6.157 (5.054–7.500)

 Moderate (41–60 dB)

410 (53.39)

358 (46.61)

25.148 (21.194–29.841)

15.120 (12.203–18.734)

17.012 (13.214–21.902)

 Severe (>60 dB)

117 (69.64)

51 (30.36)

50.376 (35.766–70.955)

31.310 (21.721–45.133)

29.566 (19.085–45.802)

HADS-A ≥8b

 No

949 (9.20)

9 368 (90.80)

1.000 ref

 

1.000 ref

 Yes

128 (13.43)

825 (86.57)

1.532 (1.257–1.867)

 

1.583 (1.225–2.044)

HADS-D ≥8b

 No

1 040 (9.49)

9 915 (90.51)

1.000 ref

 

1.000 ref

 Yes

183 (21.79)

657 (78.21)

2.655 (2.227–3.166)

 

1.429 (1.118–1.826)

Nagelkerke R2

   

0.319

0.296

−2 Log likelihood

   

6 593.252

5 200.042

  1. HADS-A = self-reported questionnaire for symptoms of anxiety in which a score of ≥8 is consistent with clinically relevant symptoms of anxiety
  2. HADS-D = self-reported questionnaire for symptoms of depression in which a score of ≥8 is consistent with clinically relevant symptoms of depression
  3. aN in this analysis ranges from 13 135 to 11 113 and 12 551 to 10 961 for respectively women and men
  4. bMissing data from several participants on this variable